EF
FOLD

Empowered Funds’s Amicus Therapeutics FOLD Stock Holding History

Empowered Funds’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,986
Closed -$246K – 2186
2026
Q1 		$246K Sell
16,986
-95,721
-85% -$1.37M ﹤0.01% 1923
2025
Q4 		$1.6M Buy
+112,707
New +$1.11M 0.03% 549
2017
Q4 		– Sell
-52,713
Closed -$795K – 108
2017
Q3 		$795K Buy
+52,713
New +$697K 0.52% 67

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Empowered Funds's FOLD Position: Q2 2026 in Review

Empowered Funds sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 16,986 shares — an estimated $246K sold.

Empowered Funds first reported a position in FOLD in Q3 2017 and held it in 3 quarters. The position peaked at $1.6M in Q4 2025. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Empowered Funds reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Empowered Funds sold 16,986 Amicus Therapeutics shares in Q2 2026, an estimated $246K.
  • Empowered Funds first reported a position in Amicus Therapeutics in Q3 2017 and held it in 3 quarters.
  • Empowered Funds's Amicus Therapeutics position peaked at $1.6M in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.